Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
ATRC
Stock Latest News
Market News
3 Small-Cap ‘Strong Buy’ Stocks with Big Upside in 2026, According to Analysts
8d ago
DEC
ATRC
Premium
Company Announcements
AtriCure Earnings Call Highlights Growth Amid Headwinds
20d ago
ATRC
Premium
Ratings
AtriCure: Underappreciated Moat, Growing Profitability, and Long-Term Upside in Underpenetrated Cardiac Markets
20d ago
ATRC
Premium
The Fly
AtriCure price target lowered to $55 from $60 at UBS
20d ago
ATRC
Premium
The Fly
AtriCure price target lowered to $53 from $64 at Canaccord
20d ago
MDT
ATRC
Premium
Ratings
AtriCure: Sustained Outperformance, Manageable Competition, and Undervalued Growth Support Buy Rating and $54 Target
20d ago
ATRC
Premium
The Fly
Oppenheimer downgrades AtriCure on new competition from Edwards
20d ago
EW
ATRC
Premium
The Fly
AtriCure downgraded to Perform from Outperform at Oppenheimer
20d ago
ATRC
Premium
The Fly
AtriCure price target lowered to $52 from $60 at Citizens
20d ago
ATRC
Premium
The Fly
Closing Bell Movers: Palo Alto Networks down 8% on soft guidance
21d ago
CE
ADI
Premium
The Fly
AtriCure sees FY26 adjusted EPS 0c-4c, consensus (1c)
21d ago
ATRC
Premium
The Fly
AtriCure reports Q4 adjusted EPS 6c, consensus (11c)
21d ago
ATRC
Premium
Pre-Earnings
ATRC Earnings this Week: How Will it Perform?
23d ago
ATRC
Premium
Ratings
AtriCure: Sustained Growth and Market Leadership Expected Despite Emerging Competition
26d ago
ATRC
Premium
Ratings
AtriCure: Solid Growth Drivers but Rising Competitive Threat from Edwards Justifies Neutral Stance
27d ago
ATRC
Premium
The Fly
AtriCure downgraded to Neutral from Overweight at JPMorgan
27d ago
EW
MDT
Premium
The Fly
AtriCure reports preliminary Q4 revenue $140.5M, consensus $139.29M
2M ago
ATRC
Premium
The Fly
AtriCure sees FY26 revenue $600M-$610M, consensus $598.59M
2M ago
ATRC
Premium
The Fly
Outset Medical appoints Prange to its board of directors
2M ago
OM
ATRC
Premium
Company Announcements
AtriCure Reports Strong Preliminary 2025 Revenue Growth
2M ago
8K
ATRC
Premium
The Fly
AtriCure price target raised to $48 from $42 at JPMorgan
3M ago
ATRC
Premium
The Fly
AtriCure announces first patients treated with dual energy platform
3M ago
ATRC
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
